Results Of Screening And Treatment For Retinopathy Of Prematurity
HALİT MÜSTAKİM, GÜNHAL ŞATIRTAV, REFİK OLTULU, HÜRKAN KERİMOĞLU, AHMET ÖZKAĞNICI, HÜSEYİN ALTUNHAN
- Year : 2017
- Vol : 33
- Issue : 2
- Page :
26-28
Objective of this study was to determine the incidence and
treatment results of retinopathy of prematurity among premature
infants followed in Neonatal Intensive Care Unit and Ophthalmology
Clinic, Meram Faculty of Medicine, Necmettin Erbakan University.
Premature infants followed between January 2012 and June 2014
were included in the study. Infants were grouped according to birth
weight and gestational age. Retinopathy of prematurity incidence,
stage and percentage of infants who were treated with Argon laser
were evaluated. Also, the treatment results and complications
of treatment were determined. The mean gestational age and the
mean birth weight of the 304 premature infants included in our
study were 31.1 ± 2.3 (24-36) weeks and 1587.58 ± 454.49 (490-
3300) gr, respectively. Retinopathy of prematurity was detected in
24.7% (75/304) of the followed infants. Retinopathy of prematurity
was recognized at the zone 2 (45 infants) most frequently, while
at the zone 1 (1 infant) was least frequently. Stage 1 (43 infants)
disease was occurred most frequently, however stage 3 (3 infants)
was observed least frequently. There was no premature infants in
stage 4 and stage 5. Aggressive posterior retinopathy of prematurity
was diagnosed in only one premature infant. A total of 45 (%60)
premature infants having retinopathy of prematurity had also plus
disease. Argon laser treatment was applied to 22 (%29.3) premature
infants with favorable results in all of them. As an important disease
retinopathy of prematurity composes a great risk of blindness for
infants with small gestational age and low birth weight. Argon laser
treatment of eyes with retinopathy of prematurity seems to be an
effective and safe alternative.
Cite this Article As :
Download Citation: Endnote/Zotero/Mendeley (RIS) RIS File
Download Citation: BibTeX BibTeX File
Description :
None of the authors, any product mentioned in this article,
does not have a material interest in the device or drug. Research,
not supported by any external organization.
grant full access to the primary data and, if requested by the magazine
they agree to allow the examination of data.
Results Of Screening And Treatment For Retinopathy Of Prematurity
2017,
Vol.
33
(2)
Received : 17.04.2017,
Accepted : 17.04.2017,
Published Online : 13.08.2018
Selçuk Tıp Dergisi
ISSN:1017-6616;
E-ISSN:2149-8059;